| Followers | 35 |
| Posts | 2799 |
| Boards Moderated | 0 |
| Alias Born | 10/28/2013 |
Friday, August 01, 2014 6:50:08 PM
I'm not assuming that you are referring to my interest in Cognate and Toucan shares sold... but you might be... and I almost clarified my interest in such yesterday.
I grind my teeth over what appears to be highly illegal, above board stock price manipulation by Adam Feuerstein. So, as many do, I daydream about writing the article that exposes him to the point of putting him out of business. But I am continually double checking my perspective, as I slowly design his orange jumpsuit.
For me, some of the strongest evidence that Feuerstein is a front (bobble-head wannabe tool) for people that seek to erase any SP spikes on good news, to keep NW off the radar for new investors, is the lack of SP rise, yet huge volume, upon substantial good news by NW, with a flimsy negative by Feuerstein. But I don't want to hang somebody who is not guilty, or as guilty as I perceive. I want to be sure that the SP did not stay flat in those instances, in part, because Cognate or Toucan took those opportunities to sell some shares.
I don't think it would be horrible for Toucan nor Cognate to sell shares upon good news. It would make sense to me, if in moderation. That's not dumping shares. That's just some income. But I doubt I will find that.
Cognate was bound by the last deal with NW to hang on to those shares for 18 months, but what about shares obtained in prior deals? There are prior shares, aren't there?
I grind my teeth over what appears to be highly illegal, above board stock price manipulation by Adam Feuerstein. So, as many do, I daydream about writing the article that exposes him to the point of putting him out of business. But I am continually double checking my perspective, as I slowly design his orange jumpsuit.
For me, some of the strongest evidence that Feuerstein is a front (bobble-head wannabe tool) for people that seek to erase any SP spikes on good news, to keep NW off the radar for new investors, is the lack of SP rise, yet huge volume, upon substantial good news by NW, with a flimsy negative by Feuerstein. But I don't want to hang somebody who is not guilty, or as guilty as I perceive. I want to be sure that the SP did not stay flat in those instances, in part, because Cognate or Toucan took those opportunities to sell some shares.
I don't think it would be horrible for Toucan nor Cognate to sell shares upon good news. It would make sense to me, if in moderation. That's not dumping shares. That's just some income. But I doubt I will find that.
Cognate was bound by the last deal with NW to hang on to those shares for 18 months, but what about shares obtained in prior deals? There are prior shares, aren't there?
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
